ロード中...
Generic and Brand-Name l-Thyroxine Are Not Bioequivalent for Children With Severe Congenital Hypothyroidism
CONTEXT: In the United States, generic substitution of levothyroxine (l-T(4)) by pharmacists is permitted if the formulations are deemed to be bioequivalent by the Federal Drug Administration, but there is widespread concern that the pharmacokinetic standard used is too insensitive. OBJECTIVE: We ai...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Endocrine Society
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3565118/ https://ncbi.nlm.nih.gov/pubmed/23264396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2012-3125 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|